EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Baseline HBsAg quantitative and CD4 T cell counts are associated with HBsAg loss in people living with HIV/HBV coinfection after combined antiretroviral therapy

Muye Xia, Yuhang Zhao, Tao Yu, Xiaoli Lin, GuiChan Liao, Yuanhui Jiang, Jingchun Mao, Jie Peng, Shaohang Cai

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1381826 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Muye Xia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Hepatitis B Surface Antigens, HIV Infections, Coinfection, Hepatitis B, Chronic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Achieving Hepatitis B surface antigen (HBsAg) loss is a significant goal for chronic hepatitis B patients. This study aims to evaluate HBsAg loss in individuals with HIV/HBV coinfection and explore the association of clinical variables with this outcome.

Methods

We enrolled 138 individuals coinfected with HIV/HBV and 480 HBV mono-infected individuals who initiated antiviral treatment. We employed Kaplan-Meier analysis to compare the rate of HBsAg loss between individuals with HIV/HBV coinfection and those with HBV mono-infection. In the HIV/HBV coinfected cohort, we used Cox proportional hazards models to assess the association between various factors and the incidence of HBsAg loss.

Results

The cumulative HBsAg loss rate was higher among HBV/HIV coinfected individuals (13 patients, 11.5% at year 3) compared to HBV mono-infected individuals (1 patient, 0.6%) after antiviral therapy. In the HIV/HBV coinfected cohort, the multivariable analysis revealed that lower baseline HBsAg level (HR 0.53; 95% CI 0.38-0.74, p<0.001) and baseline CD4 T cell counts < 180 cells/uL (HR 0.32; 95% CI 0.10-0.96, p=0.042) were associated with an increased indicator of HBsAg loss. Additionally, the receiver-operating characteristic curve analysis indicated an area under the curve of 0.771 for baseline HBsAg levels and 0.758 for baseline CD4 cell counts at year 1 in predicting HBsAg loss.

Conclusions

After antiretroviral therapy, HIV/HBV coinfected adults achieve higher rates of HBsAg loss. Baseline HBsAg quantitative and CD4 T cell counts are associated with HBsAg loss in individuals with HIV/HBV coinfection after combined antiretroviral therapy and may inform treatment decisions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B Surface AntigensHIV InfectionsCoinfectionHepatitis B, ChronicAnti-Retroviral AgentsHepatitis BHumansMaleFemaleAdultCD4 Lymphocyte CountMiddle AgedAntiviral AgentsHepatitis B virusAntiretroviral Therapy, Highly ActiveViral LoadTreatment Outcome

Stichwörter der Autor:innen

CD4 T cell countsHBsAgHBsAg lossHIV infectionhepatitis B virus

Substanzen

Hepatitis B Surface AntigensAntiviral AgentsAnti-Retroviral Agents

Autor:innen und Institutionen

  • Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • State Key Laboratory of Organ Failure Research, Guangzhou, China.
  • Key Laboratory of Infectious Diseases Research in South China (Southern Medical University), Ministry of Education, Guangzhou, China.
  • Guangdong Provincial Key Laboratory for Prevention and Control of Major Liver Diseases, Guangzhou, China.
  • Guangdong Provincial Clinical Research Center for Viral Hepatitis, Guangzhou, China.
  • Guangdong Institute of Hepatology, Guangzhou, China.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Xia, M., Zhao, Y., Yu, T., Lin, X., Liao, G., Jiang, Y., Mao, J., Peng, J., & Cai, S. (2025). Baseline HBsAg quantitative and CD4 T cell counts are associated with HBsAg loss in people living with HIV/HBV coinfection after combined antiretroviral therapy. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1381826

Vancouver

Xia M, Zhao Y, Yu T, Lin X, Liao G, Jiang Y, et al. Baseline HBsAg quantitative and CD4 T cell counts are associated with HBsAg loss in people living with HIV/HBV coinfection after combined antiretroviral therapy. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1381826

BibTeX
@article{Xia2025,
  author = {Xia, Muye and Zhao, Yuhang and Yu, Tao and Lin, Xiaoli and Liao, GuiChan and Jiang, Yuanhui and Mao, Jingchun and Peng, Jie and Cai, Shaohang},
  title = {Baseline HBsAg quantitative and CD4 T cell counts are associated with HBsAg loss in people living with HIV/HBV coinfection after combined antiretroviral therapy},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1381826}
}
Kostenlos starten →